Cargando…

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

Detalles Bibliográficos
Autores principales: Link-Gelles, Ruth, Ciesla, Allison Avrich, Fleming-Dutra, Katherine E., Smith, Zachary R., Britton, Amadea, Wiegand, Ryan E., Miller, Joseph D., Accorsi, Emma K., Schrag, Stephanie J., Verani, Jennifer R., Shang, Nong, Derado, Gordana, Pilishvili, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721148/
https://www.ncbi.nlm.nih.gov/pubmed/36454688
http://dx.doi.org/10.15585/mmwr.mm7148e1